(Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (FY)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Current assets | ||||||||
Cash, cash equivalents and short term investments | 218.61%234.58K | 180.62%250.03K | --295.6K | 172.36%353.88K | --353.88K | --73.63K | --89.1K | --129.93K |
-Cash and cash equivalents | 218.61%234.58K | 180.62%250.03K | --295.6K | 172.36%353.88K | --353.88K | --73.63K | --89.1K | --129.93K |
-Accounts receivable | 325.23%8.01K | 996.44%11.7K | --6.04K | --5.05K | --5.05K | --1.88K | --1.07K | --0 |
Total current assets | 186.77%245.21K | 139.53%261.73K | --301.63K | 176.25%358.93K | --358.93K | --85.51K | --109.26K | --129.93K |
Non current assets | ||||||||
Regulatory assets | 325.23%8.01K | 996.44%11.7K | --6.04K | --5.05K | --5.05K | --1.88K | --1.07K | --0 |
Liabilities | ||||||||
Current liabilities | ||||||||
-Total tax payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Current liabilities | 49.66%10.22K | -68.05%5.19K | --28.51K | 293.50%66.01K | --66.01K | --6.83K | --16.23K | --16.77K |
Non current liabilities | ||||||||
Total non current liabilities | 49.66%10.22K | -68.05%5.19K | --28.51K | 293.50%66.01K | --66.01K | --6.83K | --16.23K | --16.77K |
Shareholders'equity | ||||||||
Share capital | 160.45%351.6K | 160.45%351.6K | --351.6K | 170.46%351.6K | --351.6K | --135K | --135K | --130K |
-common stock | 160.45%351.6K | 160.45%351.6K | --351.6K | 170.46%351.6K | --351.6K | --135K | --135K | --130K |
Gains losses not affecting retained earnings | 220.47%37.69K | 220.47%37.69K | --37.69K | --37.69K | --37.69K | --11.76K | --11.76K | --0 |
Total equity | 186.77%245.21K | 139.53%261.73K | --301.63K | 176.25%358.93K | --358.93K | --85.51K | --109.26K | --129.93K |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.